Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 PE Firm Acquires JHP Pharmaceuticals | Contract Pharma

What are you searching for?

Sign in
Breaking News

PE Firm Acquires JHP Pharmaceuticals

Will pursue partnership and acquisition opportunities

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Warburg Pincus, a global private equity firm, has acquired JHP Pharmaceuticals for $195 million on a debt-free, cash-free basis. JHP’s current management team will continue to hold an interest in the company. Additional terms of the transaction were not disclosed.
 
JHP is specialty pharmaceutical company focused on the U.S. sterile injectable drug market. With growth capital and support from Warburg Pincus, the company will pursue partnership and acquisition opportunities in both the branded and generic segments of the sterile injectable market.
 
“Over the past five years, JHP has established itself as a strong injectable pharmaceutical business manufacturing and marketing its own branded and generic products, developing a strong generic products pipeline, and supporting other pharmaceutical companies in the development and manufacturing of innovative products,” said Stuart Hinchen, co-founder and chief executive officer of JHP. “We believe Warburg Pincus is an ideal partner for JHP’s growth and expansion in the coming years.”
 
“We have been impressed with the financial performance and quality record of JHP over the last five years, and are very pleased to contribute to the further development of the company,” said Elizabeth H Weatherman, managing director and head of Warburg Pincus’ Healthcare Group,. “The management team has done an excellent job building the company and we are delighted they are remaining with the business and co-investing. JHP represents an attractive investment opportunity for us and we have reserved a sizeable amount of additional capital to fund growth opportunities that will transform the business well beyond what it is today.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters